Functional and Morphologic Findings at Four Years After Intravitreal Bevacizumab or Laser for Type 1 ROP
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,Surgery
Reference34 articles.
1. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab
2. A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
3. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab
4. Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab
5. Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial;eClinicalMedicine;2024-05
2. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03
3. Value of optical coherence tomography angiography for the assessment of visual functions in children with retinopathy of prematurity;Russian Pediatric Ophthalmology;2023-05-05
4. Retinal and peripapillary vascular deformations in prematurely born children aged 4–12 years with a history of retinopathy of prematurity;Scientific Reports;2023-02-22
5. Bevacizumab for retinopathy of prematurity and neurodevelopment;Journal of American Association for Pediatric Ophthalmology and Strabismus;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3